Outset Medical, Inc. (OM)

NASDAQ: OM · IEX Real-Time Price · USD
16.30
+0.84 (5.43%)
Jun 24, 2022 4:00 PM EDT - Market closed
5.43%
Market Cap 779.05M
Revenue (ttm) 110.24M
Net Income (ttm) -138.80M
Shares Out 47.79M
EPS (ttm) -2.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,071,372
Open 15.55
Previous Close 15.46
Day's Range 15.26 - 16.31
52-Week Range 13.25 - 60.33
Beta n/a
Analysts Buy
Price Target 37.33 (+129.0%)
Earnings Date Aug 4, 2022

About OM

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. [Read more...]

Industry Medical Devices
IPO Date Sep 15, 2020
Employees 444
Stock Exchange NASDAQ
Ticker Symbol OM
Full Company Profile

Financial Performance

In 2021, Outset Medical's revenue was $102.60 million, an increase of 105.47% compared to the previous year's $49.94 million. Losses were -$131.94 million, 66.3% more than in 2020.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for OM stock is "Buy." The 12-month stock price forecast is 37.33, which is an increase of 129.02% from the latest price.

Price Target
$37.33
(129.02% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outset Medical, Inc. - OM

New York, New York--(Newsfile Corp. - June 25, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or the "Company") (NASDAQ: OM). Such investors are a...

3 Medical Info System Stocks Braving Industry Headwinds

Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.

Other symbols: AXNXOMCL

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,00...

Los Angeles, California--(Newsfile Corp. - June 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset...

OUTSET ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Outset Stockholders and ...

NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Outset Medical, Inc. (“Outset” or the “Co...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Inquire About Securities...

NEW YORK , June 16, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (N...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc....

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company...

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) investors concerning the Company's p...

The Law Offices of Frank R. Cruz Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) on behalf of investors concerning the Company'...

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,000 to Con...

Los Angeles, California--(Newsfile Corp. - June 15, 2022) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outse...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outset Medical, Inc. (OM...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Outset Medical, Inc...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Outset Medical, Inc. (OM) on Behalf of Inve...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) investors concerning the Company's po...

Outset Medical Plunges on Shipment Hold: Buy the Stock on the Sell-Off?

The temporary issue could present a great buying opportunity for long-term investors.

The Law Offices of Frank R. Cruz Announces Investigation of Outset Medical, Inc. (OM) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) on behalf of investors concerning the Company's...

OM INVESTOR NOTICE: Rosen Law Firm Encourages Outset Medical, Inc. Investors with Losses to Inquire About Securities ...

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM...

Why Outset Medical Shares Are Trading Lower Today

Outset Medical Inc (NASDAQ: OM) implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the FDA review and clearance of a 510(k). The company submitted for ...

Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 5...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System f...

Outset Medical to Present at Upcoming Investor Conferences

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...

2 No-Brainer Stocks to Buy Right Now for Less than $55

These companies have low share prices and high potential.

Other symbols: FLGT

Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Outset Medical Reports First Quarter 2022 Financial Results

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...

3 Healthcare Companies With Revenue Spiking 100% or More

Here's why three Fool.com contributors are bullish on Outset Medical, Aurinia Pharmaceuticals, and Shockwave Medical.

Other symbols: AUPHSWAV

Analysts Estimate Outset Medical, Inc. (OM) to Report a Decline in Earnings: What to Look Out for

Outset Medical, Inc. (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why I'm Over the Moon for This Healthcare Stock -- In One Chart

This company helps keep patients at home with dialysis treatments.

Outset Medical to Present at the BofA Securities 2022 Healthcare Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, today announced the appointment of Dale E. Jon...